These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1112 related articles for article (PubMed ID: 25484077)
1. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway. Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077 [TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. Huang Q; Wang T; Yang L; Wang HY Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819 [TBL] [Abstract][Full Text] [Related]
3. Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53. Song YM; Lee WK; Lee YH; Kang ES; Cha BS; Lee BW Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784190 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats. Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690 [TBL] [Abstract][Full Text] [Related]
6. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
7. A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway. Afshari H; Noori S; Zarghi A Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3135-3148. PubMed ID: 37209153 [TBL] [Abstract][Full Text] [Related]
8. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway. Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683 [TBL] [Abstract][Full Text] [Related]
10. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans. Banerjee J; Bruckbauer A; Zemel MB Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392 [TBL] [Abstract][Full Text] [Related]
11. Flavonones from Guo WW; Wang X; Chen XQ; Ba YY; Zhang N; Xu RR; Zhao WW; Wu X Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154382 [TBL] [Abstract][Full Text] [Related]
12. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. He Q; Sha S; Sun L; Zhang J; Dong M Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776 [TBL] [Abstract][Full Text] [Related]
13. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452 [TBL] [Abstract][Full Text] [Related]
14. Vanadium(IV)-chlorodipicolinate alleviates hepatic lipid accumulation by inducing autophagy via the LKB1/AMPK signaling pathway in vitro and in vivo. Huang Y; Liu F; Zhang F; Liu P; Xu T; Ding W J Inorg Biochem; 2018 Jun; 183():66-76. PubMed ID: 29558683 [TBL] [Abstract][Full Text] [Related]
15. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway. Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674 [No Abstract] [Full Text] [Related]
16. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice. Fu L; Bruckbauer A; Li F; Cao Q; Cui X; Wu R; Shi H; Zemel MB; Xue B Metabolism; 2015 Jul; 64(7):845-56. PubMed ID: 25858853 [TBL] [Abstract][Full Text] [Related]
17. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686 [TBL] [Abstract][Full Text] [Related]
18. SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis. Shin SY; Kim TH; Wu H; Choi YH; Kim SG Eur J Pharmacol; 2014 Mar; 727():115-24. PubMed ID: 24486702 [TBL] [Abstract][Full Text] [Related]
19. Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice. Everitt H; Hu M; Ajmo JM; Rogers CQ; Liang X; Zhang R; Yin H; Choi A; Bennett ES; You M Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G38-47. PubMed ID: 23139221 [TBL] [Abstract][Full Text] [Related]
20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]